z-logo
open-access-imgOpen Access
The SIRveNIB and SARAH trials, radioembolization vs. sorafenib in advanced HCC patients: reasons for a failure, and perspectives for the future
Author(s) -
Carlo Sposito,
Vincenzo Mazzaferro
Publication year - 2018
Publication title -
hepatobiliary surgery and nutrition
Language(s) - English
Resource type - Journals
eISSN - 2304-389X
pISSN - 2304-3881
DOI - 10.21037/hbsn.2018.10.06
Subject(s) - medicine , sorafenib , hepatocellular carcinoma , liver transplantation , stage (stratigraphy) , liver cancer , cancer , disease , oncology , curative treatment , intensive care medicine , transplantation , paleontology , biology

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom